Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

NCT05462145 is registered in ClinicalTrials.gov with Kardium Inc. as lead sponsor.

NCT NCT05462145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Lead sponsor
Kardium Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 9, 2023
Completion date
March 31, 2029
Enrollment
549 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, persistent atrial fibrillation